WARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT) has announced a 1-for-50 reverse stock split of its common ...

Aptose Biosciences (APTO) announced that its board of directors has approved, subject to required regulatory and stock exchange approvals, a ...

Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage precision oncology company ...

The Securities and Exchange Commission (SEC) recently approved rule changes proposed by The Nasdaq Stock Market LLC that impact companies ...

January 2025, the U.S. Securities and Exchange Commission (SEC) approved amendments, both of which are now effective, to The Nasdaq Stock Market ...

Nexxen International Ltd. (NASDAQ: NEXN) ("Nexxen" or the "Company"), a global, flexible advertising technology platform with deep expertise in data and advanced ...

As reports swirl that Taiwan Semiconductor (TSM) and Broadcom (AVGO) could each look to acquire parts of Intel (INTC), there ...

Windtree Therapeutics (WINT) board of directors has approved a 1-for-50 reverse stock split of the Company’s common stock. The Company’s ...

Following a rocketing higher in its stock price since beginning to add bitcoin to its balance sheet less than a year ago.

Windtree Therapeutics, Inc. (NasdaqCM: WINT) (“Windtree” or the “Company”), a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions and diseases, ...

Metaplanet announces stock split to improve liquidity, reduce investment cost, and attract more investors, effective April 1, ...